Top Markets
Coin of the day
Innovation1 Biotech Inc. Innovation1 Biotech Inc.

Innovation1 Biotech Inc.

IVBT
Rang in Aktien #42121
Innovation1 Biotech Inc. functions as a drug discovery enterprise, primarily... Innovation1 Biotech Inc. functions as a drug discovery enterprise, primarily engaged in creating modified botanical Schedule 1 molecules for use within the United States. The firm's pipeline encompasses five entirely synthetic, proprietary prodrugs that are currently in preclinical development, each designed to tackle a unique set of medical conditions. Specifically, these include a psychedelic compound derived from mushrooms, aimed at treating post-traumatic stress disorder and depression; an innovative cannabinoid and tree bark-sourced psychedelic intended to combat addiction; and three additional cannabinoid prodrugs targeting refractory pediatric epilepsy, hypertrophic scarring, and inflammation of the eye. Established in 2014 and headquartered in New York, New York, the company was previously named Gridiron BioNutrients, Inc. before adopting its current moniker, Innovation1 Biotech Inc., in March 2022.
Aktienkurs
$0.0002
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$4.49K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Innovation1 Biotech Inc. (IVBT)

Kategorie

Aktien-Split-Historie für Innovation1 Biotech Inc. (IVBT)
Die Aktie Innovation1 Biotech Inc. (Symbol: IVBT) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 13, 2026 statt.
Eine IVBT-Aktie, die vor dem Aug 13, 2026 gekauft wurde, entspricht heute 0 IVBT-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR